Literature DB >> 16171459

Molecular genetic pathways in Parkinson's disease: a review.

Shushant Jain1, Nicholas W Wood, Daniel G Healy.   

Abstract

Major progress has been made in the last decade in understanding the genetic basis of PD (Parkinson's disease) with five genes unequivocally associated with disease. As a result, multiple pathways have been implicated in the pathogenesis of PD, including proteasome impairment and mitochondrial dysfunction. Although Mendelian genetics has been successful in establishing a genetic predisposition for familial PD, this has not been reiterated in the sporadic form. In fact no genetic factors have been unequivocally associated with increased risk for sporadic PD. The difficulty in identifying susceptibility factors in PD has not only been because of numerous underpowered studies, but we have been unable to dissect out the genetic component in a multifactorial disease. This review aims to summarize the genetic findings within PD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16171459     DOI: 10.1042/CS20050106

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

Review 1.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

Review 2.  Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease.

Authors:  Robert E Burke
Journal:  Pharmacol Ther       Date:  2007-02-27       Impact factor: 12.310

3.  Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway.

Authors:  Anthony K F Liou; Rehana K Leak; Lihua Li; Michael J Zigmond
Journal:  Neurobiol Dis       Date:  2008-07-08       Impact factor: 5.996

Review 4.  Programmed cell death and new discoveries in the genetics of parkinsonism.

Authors:  Robert E Burke
Journal:  J Neurochem       Date:  2007-12-10       Impact factor: 5.372

Review 5.  The ubiquitous role of mitochondria in Parkinson and other neurodegenerative diseases.

Authors:  Georgia Theocharopoulou
Journal:  AIMS Neurosci       Date:  2020-03-25

6.  Targeted next-generation sequencing identifies novel variants in candidate genes for Parkinson's disease in Black South African and Nigerian patients.

Authors:  Oluwafemi G Oluwole; Helena Kuivaniemi; Shameemah Abrahams; William L Haylett; Alvera A Vorster; Carel J van Heerden; Colin P Kenyon; David L Tabb; Michael B Fawale; Taofiki A Sunmonu; Abiodun Ajose; Matthew O Olaogun; Anastasia C Rossouw; Ludo S van Hillegondsberg; Jonathan Carr; Owen A Ross; Morenikeji A Komolafe; Gerard Tromp; Soraya Bardien
Journal:  BMC Med Genet       Date:  2020-02-04       Impact factor: 2.103

7.  Unravelling the fibrillation mechanism of ovalbumin in the presence of mercury at its isoelectric pH.

Authors:  Manjumol Mathew; Charuvila T Aravindakumar; Usha K Aravind
Journal:  RSC Adv       Date:  2020-04-24       Impact factor: 3.361

Review 8.  Sirtuin deacetylases as therapeutic targets in the nervous system.

Authors:  Brett Langley; Anthony Sauve
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.